2024-02-09T12:34:07-05:00 2023-09-30 461041593 FINANCIAL SOLUTION ADVISORS PLLC 4350 PABLO PROFESSIONAL CT STE 200 JACKSONVILLE FL 322243224 990 2022-10-01 453710305 IDAHO VETERANS RESEARCH & EDUCATION FOUNDATION IDAH 2084221000 500 W FORT STREET BLDG 117 BOISE ID 83702 MARGARET K ALDAPE EXECUTIVE DIRECTOR 2084221000 2024-02-09 MARGARET ALDAPE 999009999 true MICHAEL B MCLEOD CPA P00966646 9042962024 2024-02-09 2022 2023-04-26 12:10:37Z MARGARET K ALDAPE 500 W FORT STREET BLDG 117 BOISE ID 83702 717830 false X WWW.IVREF.ORG X 2011 ID TO ADVANCE THE RESEARCH AND EDUCATION MISSION OF THE DEPARTMENT OF VETERANS AFFAIRS AND SPECIFICALLY THE BOISE VA MEDICAL CENTER THROUGH THE SUPPORT OF RESEARCH AND EDUCATION RELATED ACTIVITIES. 9 9 24 7 0 1242491 708008 0 733 9721 4391 101 1247615 717830 0 0 746886 691574 0 0 626942 216500 1373828 908074 -126213 -190244 840037 653845 31100 31174 808937 622671 X TO ADVANCE THE RESEARCH AND EDUCATION MISSION OF THE DEPARTMENT OF VETERANS AFFAIRS AND SPECIFICALLY THE BOISE VA MEDICAL CENTER THROUGH THE SUPPORT OF RESEARCH AND EDUCATION RELATED ACTIVITIES. false false 621730 EXPENDITURES RELATED TO RESEARCH AND EDUCATION. RESEARCH EXPENSES ASSOCIATED WITH THE FOLLOWING MAJOR GRANT PROJECTS: 1)NIH (U OF IDAHO SUB-AWARD) - IDAHO INBRE PROGRAM IVREF DOUCETTE 2)NIH (U OF IDAHO SUB-AWARD) - DHHS NIH INBRE4 IVREF VIETRI PILOT 3)NIH (U OF IDAHO SUB-AWARD) - DHHS NIH INBRE4 IVREF RADKE DRP 4)NIH R21 - ROLE OF MIR-181A-5P IN ADENOVIRUS 14P1 INDUCED ACUTE LUNG INJURY 5)NIH RO3 - DEVELOPMENT OF ANTIBODIES TO SPECIFIC CELL SURFACE MARKERS TO ASSESS MACROPHAGE POLARIZATION DURING ADENOVIRUS 14 AND 14P1 INFECTION IN THE SYRIAN HAMSTER. 6)BIOMERIEUX, INC. - UTILIZATION AND IMPACT OF URINE CULTURE & SUSCEPTIBILITY RESULTS ON THE CLINICAL OUTCOMES OF URINARY TRACT INFECTIONS IN OUTPATIENT PRIMACY CARE AND TELEHEALTH SETTINGS 7)PARATEK PHARMACEUTICALS - INVESTIGATING THE ANTI-INFLAMMATORY ACTIVITIES OF OMADACYCLINE 8)ALTO PHARMACEUTICALS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALTO-300 WITH AN OPEN-LABEL EXTENSION IN ADULTS WITH MAJOR DEPRESSIVE DISORDER. 621730 true true false false false false false false false false true false false false false true true false false false false false false false false false false false false false false false false false false false false false false false false false false true false false false true 7 0 24 true false false false false false false false false false false false false false false X 9 9 false false false false false true true true true false false true true true false false false true false false ID X MICAH ROOS 2084221000 500 WEST FORT STREET BLDG 117 BOISE ID 83702 MARGARET K ALDAPE EXECUTIVE DI 40.00 X 75706 0 0 MICAH ROOS CFO 40.00 X 67399 0 0 MARTIN BLAIR DIRECTOR 1.00 X 0 0 0 PAIGE CALHOUN DIRECTOR 1.00 X 0 0 0 MARGARET DOUCETTE PRESIDENT 4.00 X X 0 0 0 AMBER FISHER DIRECTOR 1.00 X 0 0 0 JANET HINES TREASURER 4.00 X X 0 0 0 ANGELINA KNESEL DIRECTOR 1.00 X 0 0 0 DARRELL MANNING FMR SECRETAR 4.00 X X 0 0 0 LARRY SATTERWHITE FMR TREASURE 4.00 X X 0 0 0 ANDREW WILPER VICE PRESIDE 4.00 X X 0 0 0 DAVID WOOD CHAIRMAN 4.00 X X 0 0 0 ROBERT WOOD SECRETARY 4.00 X X 0 0 0 143105 false false false 405656 302352 708008 9721 9721 CREDIT CARD REWARDS 101 101 101 717830 9822 159294 159294 452894 401499 51395 28062 12274 15788 51324 33911 17413 15000 15000 30065 23644 6421 881 256 625 8883 6502 2381 3897 2661 1236 30844 30844 3541 3541 RESEARCH SUPPLIES 106243 100081 6162 DUES AND SUBSCRIPTIONS 16749 9661 7088 SUBJECT PATIENT EXPENSE 320 320 EDUCATIONAL EXPENSES 77 77 908074 621730 286344 0 656825 119649 303978 63316 135890 20396 25672 632409 563753 99500 68656 840037 653845 31100 31174 31100 31174 X 801775 554783 7162 67888 808937 622671 840037 653845 -190244 3978 X false true X true false X 2138507 1921156 1730851 1406022 708008 7904544 1168975 1251307 292215 354200 351189 3417886 3307482 3172463 2023066 1760222 1059197 11322430 11322430 902 46690 4934 4391 101 57018 11379448 15099 0.99500 0.99600 X PART II, LINE 10 OTHER INCOME 57,018 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 632409 563753 68656 68656 X 1072997 3978 351189 355167 717830 717830 1259263 351189 351189 908074 908074 SCHEDULE D, PAGE 3, PART X THE ORGANIZATION FOLLOWS THE INCOME TAX STANDARD FOR UNCERTAIN TAX POSITIONS. THE ORGANIZATION HAS EVALUATED THEIR TAX POSITIONS AND DETERMINED THEY HAVE NO UNCERTAIN TAX POSITIONS AS OF SEPTEMBER 30, 2023 AND 2022. SHOULD THE ORGANIZATIONS TAX-EXEMPT STATUS BE CHALLENGED IN THE FUTURE, THE ORGANIZATIONS 2021, 2022, AND 2023 TAX YEARS ARE OPEN FOR EXAMINATION BY THE IRS. FORM 990, PAGE 2, PART III, LINE 4A EXPENDITURES RELATED TO RESEARCH AND EDUCATION. RESEARCH EXPENSES ASSOCIATED WITH THE FOLLOWING MAJOR GRANT PROJECTS: 1)NIH (U OF IDAHO SUB-AWARD) - IDAHO INBRE PROGRAM IVREF DOUCETTE 2)NIH (U OF IDAHO SUB-AWARD) - DHHS NIH INBRE4 IVREF VIETRI PILOT 3)NIH (U OF IDAHO SUB-AWARD) - DHHS NIH INBRE4 IVREF RADKE DRP 4)NIH R21 - ROLE OF MIR-181A-5P IN ADENOVIRUS 14P1 INDUCED ACUTE LUNG INJURY 5)NIH RO3 - DEVELOPMENT OF ANTIBODIES TO SPECIFIC CELL SURFACE MARKERS TO ASSESS MACROPHAGE POLARIZATION DURING ADENOVIRUS 14 AND 14P1 INFECTION IN THE SYRIAN HAMSTER. 6)BIOMERIEUX, INC. - UTILIZATION AND IMPACT OF URINE CULTURE & SUSCEPTIBILITY RESULTS ON THE CLINICAL OUTCOMES OF URINARY TRACT INFECTIONS IN OUTPATIENT PRIMACY CARE AND TELEHEALTH SETTINGS 7)PARATEK PHARMACEUTICALS - INVESTIGATING THE ANTI-INFLAMMATORY ACTIVITIES OF OMADACYCLINE 8)ALTO PHARMACEUTICALS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALTO-300 WITH AN OPEN-LABEL EXTENSION IN ADULTS WITH MAJOR DEPRESSIVE DISORDER. FORM 990, PAGE 6, PART VI, LINE 7A VA DIRECTORS ARE EX-OFFICIO PER THE ORGANIZATION'S BY-LAWS. OTHER DIRECTORS AND OFFICERS ARE ELECTED BY A MAJORITY VOTE OF THE BOARD OF DIRECTORS. FORM 990, PAGE 6, PART VI, LINE 7B ARTICLES AND BY-LAWS DICTATE THAT CERTAIN ACTIONS MAY BE TAKEN BY A MAJORITY VOTE OF THE VA DIRECTORS. FORM 990, PAGE 6, PART VI, LINE 11B A COPY OF THE FORM 990 IS AVAILABLE TO ALL DIRECTORS PRIOR TO FILING OF THE RETURN. THE EXECUTIVE DIRECTOR AND CHIEF FINANCE OFFICER REVIEWS THE FORM 990 BEFORE SIGNING AND REPORTS ANY ITEMS OF CONCERN TO THE OTHER DIRECTORS. FORM 990, PAGE 6, PART VI, LINE 15A THE BOARD OF DIRECTORS ARE RESPONSIBLE FOR DETERMINING, REVIEWING, AND APPROVING THE EXECUTIVE DIRECTOR'S COMPENSATION. FORM 990, PAGE 6, PART VI, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REASONABLE WRITTEN REQUEST FOR SUCH INFORMATION. BOISE VA MEDICAL CENTER 500 WEST FORT STREET BOISE ID 83702 820465077 V.A CENTER ID US GOV NA false false false false false false false false false false false false false false true false true false false false BOISE VA MEDICAL CENTER N 351189 FAIR VALUE BOISE VA MEDICAL CENTER P 24000 ACTUAL PAYROLL